AstraZeneca, GSK intensify China ties with Sino Biopharm deals
Dive Brief: China-based drugmaker Sino Biopharm said Wednesday it signed new deals with the U.K.’s two biggest pharma companies. Through one collaboration, AstraZeneca is licensing rights to a drug Sino is dev…
Read guide →